|
|

|
Health Information
|
Sunday, July 20, 2008
|
|
Find
more information about this topic from either the Web or the world's best
medical journals by using the search boxes at the top of this page.
|
| |
Lupus
Erythematosus
|
Definition
and Description
Symptoms
of SLE
Diagnosis
of SLE
Treatment
of SLE
Medications
for SLE
Psychosocial
Aspects
Health
Care Implications
|
|
| Care
for the patient with lupus erythematosus is a challenge
that draws on all the resources, knowledge, and strengths
the health care team has to offer. Because of the unpredictable,
highly individualized, and frequently changing nature of
the disease as well as the intricacy of each patient’s needs,
it is impossible to predict the treatment for one patient
from the outcome of treatment for another. Careful listening
to the person’s concerns; a cooperative, multidisciplinary
approach; and a flexible plan of care will provide the patient
with consistent, supportive care and the reassurance that
her or his needs are being attended to. |
|
|
Definition
and Description
Lupus
means “wolf.” Erythematosus
means “redness.” In 1851, doctors coined this name for
the disease because they thought the facial rash that
frequently accompanies lupus looked like the bite of a
wolf. Lupus can be categorized into three groups: discoid
lupus erythematosus, systemic lupus erythematosus, and
drug-induced systemic lupus erythematosus.
Discoid
lupus erythematosus (DLE) is characterized
by a skin rash only. It occurs in about 20% of patients
with systemic lupus erythematosus. The lesions are patchy,
crusty, sharply defined skin plaques that may scar. These
lesions are usually seen on the face or other sun-exposed
areas. DLE may cause patchy, bald areas on the scalp and
hypopigmentation or hyperpigmentation in older lesions.
Biopsy of a lesion will usually confirm the diagnosis.
Topical and intralesional corticosteroids are usually
effective for localized lesions; antimalarial drugs may
be needed for more generalized lesions. DLE only rarely
progresses to systemic lupus erythematosus.
|
|
| Systemic
lupus erythematosus (SLE, or lupus) is a chronic,
inflammatory, multisystem disorder of the immune system.
Lupus: A Patient Care Guide for Nurses and Other Health
Professionals is concerned primarily with this form
of lupus. In SLE, the body develops antibodies that react
against the person’s own normal tissue. This abnormal response
leads to the many manifestations of SLE and can be very
damaging. The course is unpredictable and individualized;
no two patients are alike. Lupus is not contagious, infectious,
or malignant. It usually develops in young women of childbearing
years, but many men and children also develop lupus. African
Americans and Hispanics have a higher frequency of this
disease than do Caucasians. SLE also appears in the first-degree
relatives of lupus patients more often than it does in the
general population, which indicates a strong hereditary
component. However, most cases of SLE occur sporadically,
indicating that both genetic and environmental factors play
a role in the development of the disease.
Lupus
varies greatly in severity, from mild cases requiring
minimal intervention to those in which significant and
potentially fatal damage occurs to vital organs such as
the lungs, heart, kidney, and brain. The disease is characterized
by “flares” of activity interspersed with periods of improvement
or remission. A flare, or exacerbation, is increased activity
of the disease process with an increase in physical manifestations
and/or abnormal laboratory test values. Periods of improvement
may last weeks, months, or even years. The disease tends
to remit over time. Some patients never develop severe
complications, and the outlook is improving for those
patients who do develop severe manifestations.
Drug-induced
SLE develops after the use of certain drugs
and has symptoms similar to those of SLE. The characteristics
of this syndrome are pleuropericardial inflammation, fever,
rash, and arthritis. Serologic changes also occur. The
clinical and serologic signs usually subside gradually
after the offending drug is discontinued. A wide
variety of drugs is implicated in this form of SLE.
|
| Drugs
Implicated as Activators of SLE
Drugs
with proven association
- Chlorpromazine
- Hydralazine
- Isoniazid
- Methyldopa
- Procainamide
Drugs
with possible association
- Beta
blockers (e.g., acebutolol, atenolol, labetalol,
metoprotolol, oxprenolol, pindolol, practolol,
and propranolol)
- Captopril
- Carbamazine
- Cimetidine
- Diphenylhydantoin
(phenytoin)
- Ethosuximide
- Methimazole
- Penicillamine
- Phenazine
- Quinidine
From:
The Bulletin on the Rheumatic Diseases, copyright
1991. Used by permission of the Arthritis Foundation.
For more information, call the Arthritis Foundation’s
information line: 1–800–283–7800.
|
|
|
Symptoms
of SLE
Early
symptoms of SLE are usually vague, nonspecific, and easily
confused with other pathological and functional disorders.
Symptoms may be transient or prolonged, and individual
symptoms often appear independently of the others. Moreover,
a patient may have severe symptoms with few abnormal laboratory
test results, and vice versa. A range of clinical
symptoms are seen in patients with lupus over the
lifetime of the disease.
Diagnosis
of SLE
The
onset of lupus may be acute, resembling an infectious
process, or it may be a progression of vague symptoms
over several years. As a result, diagnosing SLE is often
a challenge. A consistent, thorough medical examination
by a doctor familiar with lupus is essential to an accurate
diagnosis. This must include a complete medical history
and physical examination, laboratory tests, and a period
of observation (possibly years). The doctor, nurse, or
other health professional assessing a patient for lupus
must keep an open mind about the varied and seemingly
unrelated symptoms that the patient may describe. For
example, a careful medical history may show that sun exposure,
use of certain drugs, viral disease, stress, or pregnancy
aggravates symptoms, providing a vital diagnostic clue.
No
single laboratory test can definitely prove or disprove
SLE. Initial screening includes a complete blood count
(CBC), liver and kidney screening panels, laboratory tests
for specific autoantibodies (e.g., antinuclear antibodies
[ANA]), a syphilis test (VDRL), urinalysis, blood chemistries,
and erythrocyte sedimentation rate (ESR). Abnormalities
in these test results will guide further evaluations.
High-titer anti-nDNA antibody or anti-Sm antibody are
important indications of lupus. Specific immunologic studies,
such as those of complement components (e.g., C3 and C4)
and other autoantibodies (e.g., anti-La and anti-Ro),
are used to help evaluate the patient’s immune status
and to monitor the activity of the disease. At times,
biopsies of the skin or kidney using immunofluorescent
staining techniques can support a diagnosis of SLE (see,
for further information). A variety of laboratory tests,
X rays, and other diagnostic tools are used to rule out
other pathologic conditions and to determine the involvement
of specific organs. It is important to note, however,
that any single test may not be sensitive enough to reflect
the intensity of the patient’s symptoms or the extent
of the disease’s manifestations.
The American College of Rheumatology (ACR), an organization
of doctors and associated health professionals who specialize
in arthritis and related diseases of the bones, joints,
and muscles, has developed and refined a set of diagnostic
criteria. If at least 4 of the 11 criteria develop
at one time or individually over any period of observation,
then the patient is likely to have SLE. However, a diagnosis
of SLE can be made in a patient having fewer than four
of these symptoms.
|
|
Symptoms
of SLE
- Arthralgia
- Arthritis
- Fever
(>100 °F)
- Skin
rashes
- Anemia
- Kidney
damage
- Pleurisy
- Facial
rash
- Photosensitivity
- Alopecia
(hair loss)
- Raynaud’s
phenomenon
- Seizures
- Mouth
or nose ulcers
|
|
ACR
Criteria for Diagnosing SLE
- Malar
rash
- Discoid
rash
- Photosensitivity
- Oral
ulcers
- Arthritis
- Serositis
(pleuritis or pericarditis)
- Renal
disorder (persistent proteinuria or cellular casts)
- Neurological
disorder (seizures or psychosis)
- Hematologic
disorder (anemia, leukopenia or lymphopenia on
two or more occasions, thrombocytopenia)
- Immunologic
disorder (positive LE cell preparation, abnormal
anti-DNA or anti-Sm values, false-positive VDRL
syphilis test)
- Abnormal
ANA titer
Source:
Tan E. The 1982 required criteria for the classification
of systemic lupus erythematosus. Arthritis and Rheumatism
1982;25:1271–1277. © 1982 American College of Rheumatology.
Used with permission of Lippincott-Raven Publishers.
|
|
Treatment
of SLE
The
treatment of SLE is as varied as its course. Although
there is no cure for lupus and it is difficult to predict
which treatment will be most effective for each patient,
there have been significant gains in treating patients,
and there is general consensus on several treatments.
A conservative regimen of physical and emotional rest,
protection from direct sunlight, a healthful diet, prompt
treatment of infections, and avoidance of known allergens
and aggravating factors are the mainstays of lupus therapy.
In addition, for female patients, pregnancy must be planned
for times when the disease is in remission.
Physical Rest
This basic component of everyone’s good
health is essential for the lupus patient. The fatigue
of lupus is not sleepiness or tiredness from physical
exertion, but rather a frequent, persistent complaint
often described as a “bone-tired feeling” or a “paralyzing
fatigue.” Normal rest often does not refresh the patient
or eliminate the tiredness due to lupus, and fatigue may
persist despite normal laboratory test results. The patient
and family need instruction on how to use this tiredness
as a guide to activity and when the person should stop
for rest. It must be reinforced that this need for rest
is not laziness. Restful sleep of 8–10 hours per night,
naps, and “timeouts” during the day are basic guidelines;
strict bed rest is usually not required. Physical activity
should be encouraged as the patient can tolerate it. An
individualized exercise routine may facilitate recovery
from a flare and promote well-being.
Emotional Rest
A patient’s emotional stressors should be carefully assessed,
because they may play a role in triggering a flare. The
patient should be instructed on how to avoid these stressful
situations. However, the physical manifestations of lupus
must be treated as they present themselves while the emotional
stresses are explored. Discussions with the family on
this issue are essential for providing information and
in obtaining their support. Counseling for both the patient
and the family may be an option.
,
explores these issues in further detail.
Protection From Direct Sunlight
Photosensitivity is an abnormal reaction to the ultraviolet
(UV) rays of the sun and results in the development or
exacerbation of a rash that is sometimes accompanied by
systemic symptoms. About one-third of lupus patients are
photosensitive. All lupus patients should avoid direct,
prolonged exposure to the sun. Sun-sensitive patients
should frequently apply a sunscreen with a Sun Protection
Factor (SPF) of at least 15, avoid unprotected exposure
between 10 a.m. and 4 p.m., and wear protective clothing,
such as wide-brimmed hats and long sleeves. Lupus patients
should be aware that UV rays are reflected off water and
snow, and that glass, such as car windows, does not provide
total protection from UV rays.
Lupus patients should also know that fluorescent and halogen
lights may emit UV rays and can aggravate lupus. This
may be an issue for patients who work in offices lit by
these kinds of lights. Sunscreen and protective clothing
can help minimize exposure, and plastic devices are available
that block UV emissions from fluorescent or halogen light
bulbs.
Diet and Nutrition
A well-balanced diet is essential in maintaining good
health for all people, including lupus patients. There
are currently no specific dietary recommendations or limitations
for those with lupus, but a restricted diet plan may be
prescribed when fluid retention, hypertension, kidney
disease, or other problems are present. Food intolerances
and allergies may occur, but there is no evidence that
these are more common in lupus patients than in the general
population. The health professional should make a note
of the patient’s dietary history and suggest diet counseling
if appropriate, especially if the patient has a problem
with weight gain, weight loss, gastrointestinal (GI) distress,
or food intolerances. Nutritional considerations in treating
lupus patients are discussed further in Chapter 4,
Care of the Lupus Patient.
Treatment of Infections
Prompt recognition and treatment of infection is essential
for those with lupus. However, cardinal signs of infection
may be masked because of SLE treatments. For example,
a fever may be suppressed because anti-inflammatory therapy
is being given. When an infection is being treated, the
health professional should be alert to medication reactions,
especially to antibiotics.
Pregnancy and Contraception
Spontaneous abortion and premature delivery are more common
for women with SLE than for healthy women. To minimize
risks to both mother and baby, a pregnant woman with lupus
should be closely supervised by an obstetrician familiar
with lupus. The safety of oral contraceptives for women
with lupus is currently under investigation. The use of
an intrauterine device (IUD) is not recommended because
of the lupus patient’s increased risk of infection.
Surgery
Surgery may exacerbate the symptoms of SLE. Hospitalization
may be required for otherwise minor procedures, and postoperative
discharge may be delayed. If it is elective, the surgery
(including dental surgery and tooth extraction) should
be postponed until lupus activity subsides.
Immunizations
Immunizations with killed vaccines have not been shown
to exacerbate SLE. However, live vaccines with attenuated
organisms are not advisable. A lupus patient should consult
her or his doctor before receiving any immunizations,
even routine ones.
Medications for SLE
SLE
management should include as few medications for as short
a time as possible. Some patients never require medications,
and others take them only as needed or for short intervals,
but many require constant therapy with variable doses.
Despite their usefulness, no drugs are without risks.
Medications frequently used to control the symptoms are
nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarials,
corticosteroids, and immunosuppressives. Other medications
may be necessary to control specific manifestations. Before
prescribing a medication, it is helpful to scrutinize
a patient’s past response to treatments. A careful drug
history should be taken; in particular, hypersensitivities
or allergies to certain drugs should be noted, as these
may aggravate the lupus. Patient and family education
about medications and their side effects is essential.
Chapter 5, Medications Used To Treat Lupus, presents
more detailed information on this issue, and Chapter
7, Patient Information, includes relevant information
for patients.
Psychosocial
Aspects
For
the lupus patient, the emotional aspects of dealing with
a chronic disease can be overwhelming. They can also make
a patient feel isolated from friends, family, and coworkers.
Grief, depression, and anger are common reactions of patients
about their lupus.
Lupus
patients and their families deal with the disease in strikingly
different ways. Managing the ups and downs of the disease
may put strains on relationships and marriages. Younger
patients may fail to assert their independence
or develop a life away from home if they feel they cannot
cope with their disease on their own. Family members are
often confused and frightened over the changes they see
and need guidance and constructive suggestions on helping
the patient. Children of lupus patients, particularly
those too young to really understand the disease, may
need special help in coping with their parent’s illness.
It is in these areas that the patient, family, and support
systems need to be assessed, encouraged, and guided so
that they work together as a team. Allowing the patient
and her or his family time and freedom to move through
different emotional phases without criticism and unrealistic
expectations will facilitate acceptance of the disease.
The health professional can have a major role in helping
a patient adjust and can help with referrals to a social
worker, counselor, or community resource, if needed. Chapter
6, Psychosocial Aspects of Lupus, discusses these issues
in more detail.
Health
Care Implications
How
lupus is defined, diagnosed, and treated and the psychosocial
issues involved have implications for the way that the
nurse or other health professional works with a patient
who has lupus. For example, a newly diagnosed lupus patient
needs help in getting current, accurate information about
the disease and in defining realistic expectations and
goals. The Patient Information Sheets in Chapter 7,
can help. The health professional can clarify information
with the patient’s doctor, make rounds with the doctor,
and act as a liaison between the patient and the doctor,
if needed. Frequently, many doctors are involved in caring
for a lupus patient at one time. This may increase the
patient’s confusion and leave gaps in information. Emotional
support to the patient is essential. Being available for
questions, providing reassurance, and encouraging discussion
of fears and anxieties are all crucial roles that the
nurse can play.
The
lupus patient hospitalized during a flare requires symptomatic
nursing care. It is important to note that objective data,
such as anemia or sedimentation rate, may not support
subjective complaints of fatigue or pain. Careful head-to-toe
assessment and documentation of all symptoms and complaints
are important. Symptomatology changes constantly, so frequent
reassessment is necessary. Reevaluations validate a patient’s
concerns and alert the doctor to changes that may be transient
yet significant.
The
patient’s tolerance for physical activity and need to
control what she or he can do should be respected. The
patient should be involved in developing a care plan and
daily schedule of activities.
The
best way to treat lupus is to listen to the patient,
whether that patient was diagnosed today or years ago.
The patient’s support systems can be expanded to include
pamphlets and books, physical or occupational therapy,
vocational rehabilitation, homemaker services, the Visiting
Nurses Association (VNA), the Lupus Foundation of America
(LFA), and the Arthritis Foundation (AF).
Lupus
is a challenge to everyone concerned. The health professional
has a key role in its management. Accurate documentation,
supportive care, emotional support, patient education,
and access to community resources will provide the patient
and her or his family with the tools they need to cope
effectively.
|
|
|
1. Erythematosus 2. Advances 3. Tests 4. Care 5. Medications
6. Psychosocial Aspects 7. Patient Info. 8. Resources
|
| January
26, 1999 |
|
|
|